Universiteit Leiden

nl en

Thomas Hankemeier

Professor of Analytical biosciences

Name
Prof.dr. T. Hankemeier
Telephone
+31 71 527 4226
E-mail
hankemeier@lacdr.leidenuniv.nl

Thomas Hankemeier is full professor of Analytical BioSciences at the LACDR, Leiden University, since 2004. He leads as principal investigator the Analytical BioSciences and Metabolomics group, and he is the chair of the new Division of Systems Biomedicine and Pharmacology. His research is aiming at innovative analytical tools for metabolomics-driven systems biology in personalized health strategies.

More information about Thomas Hankemeier

Thomas Hankemeier is full professor of Analytical BioSciences at the LACDR, Leiden University, since 2004. He leads as principal investigator the Analytical BioSciences and Metabolomics group, and he is the chair of the new Division of Systems Biomedicine and Pharmacology.  His research is aiming at innovative analytical tools for metabolomics-driven systems biology in personalized health strategies.

In recent years he developed tools to detect, quantify and identify as many as possible metabolites in mammalian biofluids, tissues and cells. His research aims at improving sample preparation and multi-dimensional chromatographic and electro-driven separation methods, improving the interfacing to mass spectrometry, miniaturizing analytical methods using micro/nano-technology and developing methods for the identification of metabolites.

In collaboration with clinicians, biomedical researchers, biostatisticians and other –omics researchers he works on better (early) diagnosis and interventions for (cardio)vascular and metabolic diseases and neurological diseases.

He has developed a microfluidic 3D cell culture platform allowing to have 40 and more individual cell cultures with organotypic functionality. For example, he has established blood vessels, neuronal co-cultures, gut tubes in that platform, and used metabolomics to study disease mechanisms and the mechanism of action of drugs using patient-derived human cells.  

His ultimate goal is to identify early disease pathways and network changes that can be modulated by interventions to prevent or treat diseases, and support the development of novel intervention strategies to prevent or treat diseases.

He is Medical Delta Professor of Translational Epidemiology at the Department of Epidemiology at Erasmus University Medical Centre. He is the Scientific Director of the Netherlands Metabolomics Centre ( www.metabolomicscentre.nl). He is co-founder of  MIMETAS, the worldwide first organ-on-a-chip company. He has a MSc in chemistry and a PhD in analytical chemistry.  From 1996 to 2004 he was responsible as a scientific Product Manager at the department of Analytical Sciences at TNO for research in the fields of food safety, food quality and metabolomics.

Professor of Analytical biosciences

  • Wiskunde en Natuurwetenschappen
  • Leiden Academic Centre for Drug Research
  • LACDR/Analytical Biosciences

Work address

Science Campus
Einsteinweg 55
2333 CC Leiden
Room number GW4.07

Contact

Publications

  • Member of Scientific Advisory Board of DSM Advies
  • Agios consultancy
  • Mimetas Co-founder
  • Astellas Consultancy
  • DSM Consultancy

This website uses cookies. Read more